Navigation Links
Shire's Replenished Portfolio Drives Excellent Quarterly Performance
Date:4/29/2010

ber of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of Shire's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure new products for commercialization and/or development; government regulation of Shire's products; Shire's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on Shire's products; Shire's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; Shire's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in Shire's filings with the Securities and Exchange Commission.

Non GAAP Measures

This press release contains financial measures not prepared in accordance with US GAAP. These measures are referred to as "Non GAAP" measures and include: Non GAAP operating income; Non GAAP net income; Non GAAP diluted earnings per ADS; effective tax rate on Non GAAP income from continuing operations before income taxes and earnings of equity method investees ("Effective tax rate on Non GAAP income"); Non GAAP cost of product sales; Non GAAP research and development; Non GAAP selling, general and administrative; Non GAAP other income; and Non GAAP cash generation. These Non GAAP measures exclude the effect of certain cash and non-cash items, both recurring and non-recurring, that Shire's management believes are not related to the core performance of Shire's business.

These Non GAAP fi
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
2. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
3. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
4. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
5. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
6. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
7. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
8. Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
9. EUCODIS Bioscience Launches Lipase Portfolio
10. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
11. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 ... that Roger Jeffs , Ph.D., President and Co-Chief Executive ... on the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on ... can be accessed via a live webcast on the United ...
(Date:4/30/2015)... , April 30, 2015  Roka Bioscience, Inc. ... on providing advanced testing solutions for the detection of ... for the first quarter of 2015 on May 7, ... Roka Bioscience will also host a conference call ... to discuss its first quarter financial results. During the ...
(Date:4/30/2015)... San Francisco, CA (PRWEB) April 30, 2015 ... for the first quarter of 2015 were $4.4 million, compared ... The net loss for the first quarter was $8.9 million, ... to a net loss for the same period in 2014, ... share. As of March 31, 2015, cash, cash equivalents and ...
(Date:4/30/2015)... Nitto Avecia, a leading biotechnology ... capacity and production capability to serve biotechnology pharmaceutical ... service fulfillment continues to drive Nitto Avecia to ... capacities. , In Fall 2014, Nitto ... equipment at its Milford, MA facility, which is ...
Breaking Biology Technology:Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... following is a statement issued,September 12 by former Banc of ... Corp. (NYSE: BVF ) to drop its lawsuit,against him ... "I am pleased that Biovail has dropped the baseless ... of claims," Mr. Maris,said. "However, contrary to the suggestion ...
... CORDOVA, Calif., Sept. 12 ,ThermoGenesis Corp. (Nasdaq: KOOL ... therapy, today reported results for the fourth,quarter and all ... June 30, 2007 were $3,520,000 compared,with revenues of $3,557,000 ... the Company,s stem cell therapy activities were $2,443,000,versus $2,708,000 ...
... Sigma-Aldrich (Nasdaq:,SIAL) has announced its intent to invest ... located northwest of Shanghai, China, for its new ... understanding,with the WND authorities. The site is ... to,initially invest $25 million to acquire land rights ...
Cached Biology Technology:ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 2ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 3ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 4ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 5ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 6ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results 7Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth 2Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth 3
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM FOR ... introduces a new revolutionary method and system to ... of miniature antenna modules for multiple purposes including ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... are more positive than negative now with regards to the ... way to go." Considerable progress has been made in ... continues to generate smoke from the open mine. Fire ... there are still "weeks of firefighting ahead" according to Craig ...
... Coral Gables, Fla (Feb. 19, 2014) -- There are more ... of connections in our brains. Each of these neurons contains ... proteins interact to form the complex networks of the brain ... unravel. , For the first time, a group of ...
... Jackson Laboratory Assistant Professor Gareth Howell, Ph.D., is one of ... The New York Academy of Medicine (NYAM). The Lewis ... glaucoma published in a peer-reviewed journal in the prior calendar ... of peer researchers selects one winning article, whose author receives ...
Cached Biology News:Watching how the brain works 2Jackson Laboratory researcher Gareth Howell, Ph.D., receives Lewis Rudin Glaucoma Prize 2
... to Synaptogyrin 2 ( Abpromise ... Antigen: ... Internal sequence amino acids 42-57 ... Entrez Gene ID: ...
...
... and low background ,This solution greatly enhances ... higher than obtained with conventional methods. ,Two ... and secondary antibodies, which can suppress the ... , Wide versatility ,It is applicable to ...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Biology Products: